Effects of Mobility Dose on Discharge Disposition in Critically Ill Stroke Patients

Completed

Conditions studied: Sarcopenia, Stroke, Acute, Muscle Weakness, Critical Illness

In brief

The primary aim of the study is to assess the mobility dose in neurocritical care patients with ischemic stroke or intracranial hemorrhage and its effects on discharge disposition and patient outcomes. The investigators hypothesize that patients' mobilization dose in the intensive care unit (ICU) predicts discharge disposition, 90 day Barthel Index and other outcomes like muscle wasting (expressed as decrease in rectus femoris cross sectional area (RF-CSA) in the paretic and non-paretic limb measured by bedside ultrasound), and ICU length of stay (LOS).

Key facts

Study ID
NCT03347656
Run by
Beth Israel Deaconess Medical Center
People needed
164
Starts
2017-10-12
Expected to finish
2021-06-30
Last updated by the study team
2024-08-20

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.